Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD

Thorax

Volumn 62, Issue 2, 2007, Pages 109-114

  Bolton, Charlotte E ^a   Broekhuizen, Roelinka ^b   Ionescu, Alina A ^a   Nixon, Lisette S ^a   Wouters, Emiel F M ^b   Shale, Dennis J ^a   Schols, Annemie M W J ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; INTERLEUKIN 6; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; PSEUDOURIDINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HAND GRIP; HUMAN; INFLAMMATION; KIDNEY CLEARANCE; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; NUTRITIONAL ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PULMONARY REHABILITATION; SKELETAL MUSCLE; WORKLOAD;

BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE, SKELETAL; PROTEINS; PSEUDOURIDINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847013344     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.060368     Document Type: Article

References (41)

1. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005;82:53-9.
2. Shoup R, Dalsky G, Warner S, et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 1997;10:1576-80.
3. Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-93.
4. Donahoe M, Rogers RM, Wilson DO, et al. Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989;94:1260-3.
5. Debigaré R, Marquis K, Côté CH, et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest 2003;124:83-9.
6. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1414-18.
7. Engelen MPKJ, Deutz NEP, Wouters EFM, et al. Enhanced levels of whole-body protein turnover in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:1488-92.
8. Engelen MPKJ, Deute NEP, Mostert R, et al. Response of whole-body protein and urea turnover to exercise differs between patients with chronic obstructive pulmonary disease with and without emphysema. Am J Clin Nutr 2003;77:868-74.
9. 3)-leucine turnover and urinary pseudouridine concentration in patients with Ullrich-Turner syndrome. Eur J Pediatr 1996;155:275-80.
10. Gehrke CW, Kuo KC, Waalkes TP, et al. Patterns of urinary excretion of modified nucleosides. Cancer Res 1979;39:1150-3.
11. Itoh K, Aida S, Ishiwata S, et al. Urinary excretion patterns of modified nucleosides, pseudouridine and 1-methyladenosine in healthy individuals. Clin Chim Acta 1993;217:221-3.
12. Topp H, Unverzagt S, Rudloff S, et al. Diurnal variation in the renal excretion of modified RNA catabolites in humans. Clin Sci 2003;105:195-202.
13. Lu J, Lai R, Liang L, et al. Evaluation of urinary pseudouridine as a tumour marker in lung cancer. J Formos Med Assoc 1994;93:25-9.
14. Intrieri M, Calcagno G, Oriani G, et al. Pseudouridine and 1-ribosylpyridin-4-one-3-carboxamide (PCNR) serum concentrations in human immunodeficiency virus type - infected patients are independent predictors for AIDS progression. J Infect Dis 1996;174:199-203.
15. Ionescu AA, Nixon LS, Luzio S, et al. Pulmonary function, body composition, and protein catobolism in adults with cystic fibrosis. Am J Respir Crit Care Med 2002;165:495-500.
16. Baarends AM, Schols AMWJ, Mostert R, et al. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2807-13.
17. Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994;7:1793-7.
18. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;19:617-25.
19. Agusti AG, Sauleda J, Miralles C, et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:485-9.
20. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
21. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46.
22. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet 1996;348:1115-19.
23. Bendstrup KE, Ingemann Jensen J, Holm S, et al. Out-patient rehabilitation improves activities of daily living, quality of life and exercise tolerance in chronic obstructive pulmonary disease. Eur Respir J 1997;10:2801-6.
24. Bernard S, Whittom F, Leblanc P, et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:896-901.
25. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
26. Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 1995;152:1268-74.
27. Steiner MC, Barton RL, Singh SJ, et al. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003;58:745-51.
28. Creutzberg EC, Wouters EF, Mostert R, et al. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition 2003;19:120-7.
29. Franssen FME, Broekhuizen R, Janssen PP, et al. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest 2004;125:2021-8.
30. Schols A, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1791-7.
31. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention or chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
32. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22:1-2.
33. Li Y, Wang S, Zhong N. Simultaneous determination of pseudouridine and creatinine in urine of normal children and patients with leukaemia by high performance liquid chromatography. Biomed Chromatogr 1992;6:191-3.
34. Steiner MC, Barton RL, Singh SJ, et al. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626-31.
35. Leeuwenberg JF, Dentener MA, Buurman WA. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability- increasing protein. J Immunol 1994;152:5070-6.
36. Gosker HR, Schrauwen P, Hesselink MK, et al. Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD. Eur Respir J 2003;22:88-93.
37. Di Francia M, Barbier D, Mege JL, et al. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994;150:1453-5.
38. Schols AM, Buurman WA, Staal van den Brekel AJ, et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51:819-24.
39. Rabinovich RA, Figueras M, Ardite E, et al. Increased tumour necrosis factor-α plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J 2003;21:789-94.
40. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683-93.
41. Tebib JC, Reynaud C, Cedoz JP, et al. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process. Br J Rheumatol 1997;36:990-5.